Swiss National Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Buy
288,600
+13,300
+5% +$525K 0.01% 851
2025
Q1
$8.31M Sell
275,300
-3,900
-1% -$118K 0.01% 982
2024
Q4
$9.76M Buy
279,200
+22,600
+9% +$790K 0.01% 959
2024
Q3
$10.3M Sell
256,600
-1,400
-0.5% -$56.1K 0.01% 923
2024
Q2
$12.3M Buy
258,000
+3,100
+1% +$148K 0.01% 799
2024
Q1
$11M Buy
254,900
+600
+0.2% +$26K 0.01% 867
2023
Q4
$12.9M Sell
254,300
-28,800
-10% -$1.46M 0.01% 781
2023
Q3
$12.8M Buy
283,100
+3,000
+1% +$136K 0.01% 777
2023
Q2
$11.5M Buy
280,100
+4,200
+2% +$172K 0.01% 835
2023
Q1
$9.86M Sell
275,900
-32,500
-11% -$1.16M 0.01% 874
2022
Q4
$11.6M Buy
308,400
+5,800
+2% +$219K 0.01% 836
2022
Q3
$13.4M Buy
302,600
+3,300
+1% +$146K 0.01% 747
2022
Q2
$11.1M Sell
299,300
-1,200
-0.4% -$44.4K 0.01% 860
2022
Q1
$11.1M Buy
300,500
+21,200
+8% +$785K 0.01% 961
2021
Q4
$8.5M Sell
279,300
-600
-0.2% -$18.3K 0.01% 1110
2021
Q3
$9.39M Hold
279,900
0.01% 1034
2021
Q2
$11.2M Sell
279,900
-230,459
-45% -$9.19M 0.01% 954
2021
Q1
$22.9M Buy
510,359
+8,700
+2% +$391K 0.02% 656
2020
Q4
$28.4M Sell
501,659
-13,800
-3% -$780K 0.02% 594
2020
Q3
$24.5M Sell
515,459
-13,000
-2% -$617K 0.02% 578
2020
Q2
$31.2M Buy
528,459
+9,700
+2% +$572K 0.03% 513
2020
Q1
$24.5M Buy
518,759
+97,900
+23% +$4.63M 0.03% 498
2019
Q4
$25.4M Sell
420,859
-19,300
-4% -$1.17M 0.03% 547
2019
Q3
$26.4M Buy
440,159
+11,459
+3% +$687K 0.03% 524
2019
Q2
$27.6M Buy
428,700
+190,600
+80% +$12.3M 0.03% 525
2019
Q1
$19.3M Buy
238,100
+7,500
+3% +$609K 0.02% 586
2018
Q4
$12.5M Buy
230,600
+11,700
+5% +$632K 0.02% 620
2018
Q3
$11.3M Buy
218,900
+2,200
+1% +$113K 0.01% 692
2018
Q2
$9.03M Hold
216,700
0.01% 770
2018
Q1
$9.55M Buy
216,700
+4,900
+2% +$216K 0.01% 731
2017
Q4
$10.7M Buy
211,800
+4,500
+2% +$226K 0.01% 685
2017
Q3
$10.5M Buy
207,300
+5,400
+3% +$274K 0.01% 680
2017
Q2
$10.3M Buy
201,900
+1,700
+0.8% +$86.5K 0.01% 674
2017
Q1
$8.05M Buy
200,200
+1,400
+0.7% +$56.3K 0.01% 748
2016
Q4
$9.51M Sell
198,800
-37,400
-16% -$1.79M 0.02% 670
2016
Q3
$8.65M Sell
236,200
-102,000
-30% -$3.74M 0.01% 679
2016
Q2
$7.88M Buy
338,200
+26,100
+8% +$608K 0.01% 714
2016
Q1
$12.1M Buy
312,100
+95,100
+44% +$3.69M 0.02% 590
2015
Q4
$13.4M Buy
217,000
+3,400
+2% +$211K 0.03% 501
2015
Q3
$8.63M Buy
213,600
+21,600
+11% +$873K 0.02% 592
2015
Q2
$11.1M Buy
192,000
+12,000
+7% +$691K 0.03% 558
2015
Q1
$11.5M Buy
180,000
+49,700
+38% +$3.16M 0.03% 532
2014
Q4
$8.05M Buy
130,300
+3,000
+2% +$185K 0.03% 501
2014
Q3
$4.94M Sell
127,300
-1,600
-1% -$62.1K 0.02% 703
2014
Q2
$4.44M Hold
128,900
0.02% 795
2014
Q1
$5.57M Buy
128,900
+29,200
+29% +$1.26M 0.02% 655
2013
Q4
$3.97M Buy
99,700
+2,200
+2% +$87.6K 0.02% 700
2013
Q3
$3.66M Sell
97,500
-4,800
-5% -$180K 0.02% 701
2013
Q2
$2.75M Buy
+102,300
New +$2.75M 0.01% 815